SCHEMBL10019233

SCHEMBL10019233

[C-]#[N+]c1ccc(OC)c(O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TUBB1 Q9H4B7 9/20 0.47
ALDH1A1 P00352 1/20 0.47
AOX1 Q06278 1/20 0.47
CYP1A2 P05177 2/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 2/20 0.44
CYP3A4 P08684 1/20 0.44
NFKB1 P19838 1/20 0.44
ALOX15 P16050 1/20 0.44
ALOX12 P18054 1/20 0.44
APP P05067 1/20 0.44
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
TP53 P04637 1/20 0.43
TUBB4A P04350 5/20 0.43
TUBB P07437 5/20 0.43
TUBA3C P0DPH7 5/20 0.43
TUBA1B P68363 5/20 0.43
TUBA4A P68366 5/20 0.43
TUBB4B P68371 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12024944 0.84 MAOB (0.55) ALDH1A1TSHRCA1CA2TP53
SCHEMBL5856821 0.81 CA2 (0.48) TUBB1ALDH1A1CYP1A2TSHRCYP3A4
SCHEMBL12659805 0.78 ACHE (0.40) ALDH1A1MAPTTSHRCYP3A4ALOX15
SCHEMBL29956009 0.76 ALDH1A1 (0.40) ALDH1A1MAPTALOX15ALOX12TP53
SCHEMBL12024940 0.76 ALDH1A1 (0.47) TUBB1ALDH1A1CYP1A2MAPTMEN1
SCHEMBL29954325 0.73 LRRK2 (0.35) CA1CA2
SCHEMBL11959890 0.73 ACHE (0.35) TUBB1ALDH1A1MAPTCYP3A4CA1
SCHEMBL2706567 0.73 APP (0.43) ALDH1A1MAPTALOX15APPCA1
SCHEMBL12024943 0.73 TAAR1 (0.42) ALDH1A1CA2MEN1KMT2A
SCHEMBL68212 0.72 MAOB (0.67) TUBB1ALDH1A1AOX1CYP1A2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101619-B2 Phenylpiperazine derivatives with a combination of partial dopamine-D2 receptor agonism and serotonin reuptake inhibition SOLVAY PHARMACEUTICALS B.V. (NL) 2012-01-24 US disclosed
US-7705145-B2 Process for the preparation of 4-(3′-chloro-4′-fluoroanilino) -7-methoxy-6-(3-morpholinopropoxy) quinazoline ASTRAZENECA AB (SE) 2010-04-27 US disclosed